Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Fateeha Furqan & Nirav N Shah. (2022) Bispecific CAR T-cells for B-cell Malignancies. Expert Opinion on Biological Therapy 22:8, pages 1005-1015.
Read now
Read now
Jayalakshmi Balakrishna, Neil Basumallik, Robert Matulonis, Drake Scott, Dalia Salem, Gregory Jasper, Adrian Wiestner, Maryalice Stetler-Stevenson, Gerald Marti, Clare Sun & Constance M. Yuan. (2021) Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma. Leukemia & Lymphoma 62:8, pages 1828-1839.
Read now
Read now
Nashwa Khairat Abousamra, Manal Salah El-Din, Eman Hamza Elzahaf & Mohammed Ebrahim Esmael. (2015) Ectonucleoside triphosphate diphosphohydrolase-1 (E-NTPDase1/CD39) as a new prognostic marker in chronic lymphocytic leukemia. Leukemia & Lymphoma 56:1, pages 113-119.
Read now
Read now
Pauline Y. Huang, O. Giles Best, Larissa Belov, Stephen P. Mulligan & Richard I. Christopherson. (2012) Surface profiles for subclassification of chronic lymphocytic leukemia. Leukemia & Lymphoma 53:6, pages 1046-1056.
Read now
Read now
Massimo Gentile, Anna Grazia Recchia, Ernesto Vigna, Carla Mazzone, Eugenio Lucia, Vincenzo Gigliotti, Sabrina Bossio, Antonio Madeo, Lucio Morabito, Pasquale Servillo, Stefania Franzese, Nadia Caruso, Laura De Stefano, Maria Grazia Bisconte, Carlo Gentile & Fortunato Morabito. (2011) Lenalidomide in the treatment of chronic lymphocytic leukemia. Expert Opinion on Investigational Drugs 20:2, pages 273-286.
Read now
Read now
David Masiello & Anil Tulpule. (2009) Bendamustine therapy in chronic lymphocytic leukemia. Expert Opinion on Pharmacotherapy 10:10, pages 1687-1698.
Read now
Read now
Amjad Hayat, David O'Brien, Paul O'Rourke, Siobhan McGuckin, Tony Fitzgerald, Eibhlin Conneally, Paul V. Browne, Shaun R. Mccann, Mark P. Lawler & Elisabeth Vandenberghe. (2006) CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia. Leukemia & Lymphoma 47:11, pages 2371-2379.
Read now
Read now
ZOLTAN MATRAI. (2005) CD38 as a prognostic marker in CLL. Hematology 10:1, pages 39-46.
Read now
Read now
Chung-Che Chang, Cheng Z. Liu & Ronald P. Cleveland. (2003) Relative Importance of CD38 Expression Over Myeloid-associated Markers Expression in Predicting the Clinical Course of B-CLL Patients. Leukemia & Lymphoma 44:6, pages 977-982.
Read now
Read now
Giovanni D'Arena, Nicola Di Renzo, Maura Brugiatelli, Maria L. Vigliotti & Michael J. Keating. (2003) Biological and Clinical Heterogeneity of B-cell Chronic Lymphocytic Leukemia. Leukemia & Lymphoma 44:2, pages 223-228.
Read now
Read now
Articles from other publishers (53)
Fateeha FurqanNirav N. Shah. (2023) Multispecific CAR T Cells Deprive Lymphomas of Escape via Antigen Loss. Annual Review of Medicine 74:1, pages 279-291.
Crossref
Crossref
Pranab DeyPranab Dey. 2021. Diagnostic Flow Cytometry in Cytology. Diagnostic Flow Cytometry in Cytology
97
107
.
Nina Kreuzberger, Johanna AAG Damen, Marialena Trivella, Lise J Estcourt, Angela Aldin, Lisa Umlauff, Maria DLA Vazquez-Montes, Robert Wolff, Karel GM Moons, Ina Monsef, Farid Foroutan, Karl-Anton Kreuzer & Nicole Skoetz. (2020) Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis. Cochrane Database of Systematic Reviews 2020:7.
Crossref
Crossref
Jared A. Cohen, Riccardo Bomben, Federico Pozzo, Erika Tissino, Andrea Härzschel, Tanja Nicole Hartmann, Antonella Zucchetto & Valter Gattei. (2020) An Updated Perspective on Current Prognostic and Predictive Biomarkers in Chronic Lymphocytic Leukemia in the Context of Chemoimmunotherapy and Novel Targeted Therapy. Cancers 12:4, pages 894.
Crossref
Crossref
Eri Katsuyama, Abel Suarez-Fueyo, Sean J. Bradley, Masayuki Mizui, Ana V. Marin, Lama Mulki, Suzanne Krishfield, Fabio Malavasi, Joon Yoon, Shannan J. Ho Sui, Vasileios C. Kyttaris & George C. Tsokos. (2020) The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections. Cell Reports 30:1, pages 112-123.e4.
Crossref
Crossref
Aysun Şentürk Yikilmaz, Sema Akinci, Şule Mine Bakanay, Zeynep Büşra Zengin & İmdat Dilek. (2019) Is Cd11c and Fmc7 Negativity in Chronic Lymphocytic Leukemia Poor Prognostic?. Indian Journal of Hematology and Blood Transfusion 36:1, pages 84-90.
Crossref
Crossref
Kamil Wdowiak, Enrique Gallego‑Colon, Tomasz Francuz, Paulina Czajka‑Francuz, Natalia Ruiz‑Agamez, Marcin Kubeczko, Iga Grochoła, Maciej Wybraniec, Jerzy Chudek & Jerzy Wojnar. (2018) Increased serum levels of Galectin‑9 in patients with chronic lymphocytic leukemia. Oncology Letters.
Crossref
Crossref
Prajwal Boddu & Alessandra Ferrajoli. (2018) Prognostic Factors in the Era of Targeted Therapies in CLL. Current Hematologic Malignancy Reports 13:2, pages 78-90.
Crossref
Crossref
Alain Mina, Jose Sandoval Sus, Elsa Sleiman, Javier Pinilla-Ibarz, Farrukh T. Awan & Mohamed A. Kharfan-Dabaja. (2018) Using prognostic models in CLL to personalize approach to clinical care: Are we there yet?. Blood Reviews 32:2, pages 159-166.
Crossref
Crossref
Robert J. MacDonald, Jonathan H. Shrimp, Hong Jiang, Lu Zhang, Hening Lin & Andrew Yen. (2017) Probing the requirement for CD38 in retinoic acid-induced HL-60 cell differentiation with a small molecule dimerizer and genetic knockout. Scientific Reports 7:1.
Crossref
Crossref
Wojciech Gorczyca. 2017. Flow Cytometry in Neoplastic Hematology. Flow Cytometry in Neoplastic Hematology
115
125
.
Carlos I. Amaya-Chanaga & Laura Z. Rassenti. (2016) Biomarkers in chronic lymphocytic leukemia: Clinical applications and prognostic markers. Best Practice & Research Clinical Haematology 29:1, pages 79-89.
Crossref
Crossref
Paolo Strati, Lynne V. Abruzzo, William G. Wierda, Susan O'Brien, Alessandra Ferrajoli & Michael J. Keating. (2015) Second Cancers and Richter Transformation Are the Leading Causes of Death in Patients With Trisomy 12 Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma and Leukemia 15:7, pages 420-427.
Crossref
Crossref
Paul R. J. Ames, Darren Aw & Mervin G. Rainey. (2013) Autoimmune haemolytic anaemia emerging during Campath treatment in a patient with CD5 negative chronic lymphocytic leukaemia. Indian Journal of Hematology and Blood Transfusion 30:S1, pages 43-45.
Crossref
Crossref
John C. RichesConor J. O’DonovanSarah J. KingdonFabienne McClanahanAndrew J. ClearDonna S. NeubergLillian WernerCarlo M. Croce, Alan G. RamsayLaura Z. Rassenti, Thomas J. Kipps & John G. Gribben. (2014) Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations. Blood 123:26, pages 4101-4110.
Crossref
Crossref
Jonathan H. Shrimp, Jing Hu, Min Dong, Brian S. Wang, Robert MacDonald, Hong Jiang, Quan Hao, Andrew Yen & Hening Lin. (2014) Revealing CD38 Cellular Localization Using a Cell Permeable, Mechanism-Based Fluorescent Small-Molecule Probe. Journal of the American Chemical Society 136:15, pages 5656-5663.
Crossref
Crossref
Sandeep S. Dave. (2013) Genomic stratification for the treatment of lymphomas. Hematology 2013:1, pages 331-334.
Crossref
Crossref
Paula Cramer & Michael Hallek. (2010) Prognostic factors in chronic lymphocytic leukemia—what do we need to know?. Nature Reviews Clinical Oncology 8:1, pages 38-47.
Crossref
Crossref
D A MacIntyre, B Jiménez, E Jantus Lewintre, C Reinoso Martín, H Schäfer, C García Ballesteros, J Ramón Mayans, M Spraul, J García-Conde & A Pineda-Lucena. (2010) Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups. Leukemia 24:4, pages 788-797.
Crossref
Crossref
Gustav Lehne, Unn-Hilde Grasmo-Wendler, Jeanne-Marie Berner, Leonardo A. Meza-Zepeda, Birgitte Lid Adamsen, Aksel Flack, Andrew Reiner, Ole Petter Fraas Clausen, Eivind Hovig & Ola Myklebost. (2009) Upregulation of stem cell genes in multidrug resistant K562 leukemia cells. Leukemia Research 33:10, pages 1379-1385.
Crossref
Crossref
Nashwa Khayrat Abousamra, Manal Salah EL‐Din & Emad Azmy. (2009) T‐cell CD38 expression in B‐chronic lymphocytic leukaemia. Hematological Oncology 27:2, pages 82-89.
Crossref
Crossref
Wei Xu, Jian-Yong Li, Yu-Jie Wu, Hui Yu, Qiu-Dan Shen, Tian Tian, Li Li & Hong-Xia Qiu. (2009) CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia. Leukemia Research 33:2, pages 237-243.
Crossref
Crossref
Petra Korać, Radmila Ajduković, Mirjana Mariana Kardum Paro, Branimir Jakšić & Mara Dominis. (2009) Immunohistochemical analysis of ZAP-70 expression in chronic lymphocytic leukemia. Journal of Molecular Histology 40:1, pages 81-86.
Crossref
Crossref
Femke Van Bockstaele, Bruno Verhasselt & Jan Philippé. (2009) Prognostic markers in chronic lymphocytic leukemia: A comprehensive review. Blood Reviews 23:1, pages 25-47.
Crossref
Crossref
Miaoqing Shen & Andrew Yen. (2008) c-Cbl Interacts with CD38 and Promotes Retinoic Acid–Induced Differentiation and G0 Arrest of Human Myeloblastic Leukemia Cells. Cancer Research 68:21, pages 8761-8769.
Crossref
Crossref
Fabio Malavasi, Silvia Deaglio, Ada Funaro, Enza Ferrero, Alberto L. Horenstein, Erika Ortolan, Tiziana Vaisitti & Semra Aydin. (2008) Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology. Physiological Reviews 88:3, pages 841-886.
Crossref
Crossref
Sandra Quijano, Antonio López, Ana Rasillo, José María Sayagués, Susana Barrena, Maria Luz Sánchez, Cristina Teodosio, Pilar Giraldo, Manuel Giralt, M. Carmen Pérez, Mercedes Romero, Luis Perdiguer & Alberto Orfao. (2007) Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B‐cells in chronic lymphocytic leukemia. Cytometry Part B: Clinical Cytometry 74B:3, pages 139-149.
Crossref
Crossref
H. Merle-Béral & M. Le Garff-Tavernier. (2008) Immunophénotypage des hémopathies malignes par cytométrie de flux. EMC - Hématologie 3:3, pages 1-12.
Crossref
Crossref
Stephen M. Jackson, Patrick C. Wilson, Judith A. James & J. Donald Capra. 2008. Advances in Immunology Volume 98. Advances in Immunology Volume 98
151
224
.
P R J Ames, D Aw & M G Rainey. (2007) Campath in haemolytic anaemia and chronic lymphatic leukaemia: an unsuccessful case. Leukemia 21:11, pages 2380-2381.
Crossref
Crossref
Giovanni D'Arena, Michela Tarnani, Carlo Rumi, Tiziana Vaisitti, Semra Aydin, Rosaria De Filippi, Francesco Perrone, Antonio Pinto, Patrizia Chiusolo, Silvia Deaglio, Fabio Malavasi & Luca Laurenti. (2007) Prognostic significance of combined analysis of ZAP‐70 and CD38 in chronic lymphocytic leukemia. American Journal of Hematology 82:9, pages 787-791.
Crossref
Crossref
William G. WierdaSusan O'BrienXuemei Wang, Stefan FaderlAlessandra FerrajoliKim-Anh Do, Jorge CortesDeborah ThomasGuillermo Garcia-ManeroCharles KollerMiloslav BeranFrancis GilesFarhad RavandiSusan LernerHagop KantarjianMichael Keating. (2007) Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia. Blood 109:11, pages 4679-4685.
Crossref
Crossref
C Pepper, R Ward, T T Lin, P Brennan, J Starczynski, M Musson, C Rowntree, P Bentley, K Mills, G Pratt & C Fegan. (2007) Highly purified CD38+ and CD38− sub-clones derived from the same chronic lymphocytic leukemia patient have distinct gene expression signatures despite their monoclonal origin. Leukemia 21:4, pages 687-696.
Crossref
Crossref
Silvia DeaglioTiziana VaisittiSemra AydinEnza FerreroFabio Malavasi. (2006) In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia. Blood 108:4, pages 1135-1144.
Crossref
Crossref
Sarah J. RichardsonChristine MatthewsMark A. CatherwoodH. Denis AlexanderB. Sean CareyJoanna FarrugiaAnne GardinerSarah MouldDavid OscierJ. Adrian CopplestoneArchibald G. Prentice. (2006) ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL). Blood 107:9, pages 3584-3592.
Crossref
Crossref
Thomas J. Lamkin, Vivian Chin, Susi Varvayanis, James L. Smith, R. Michael Sramkoski, James W. Jacobberger & Andrew Yen. (2006) Retinoic acid-induced CD38 expression in HL-60 myeloblastic leukemia cells regulates cell differentiation or viability depending on expression levels. Journal of Cellular Biochemistry 97:6, pages 1328-1338.
Crossref
Crossref
C Pepper, P Brennan, S Alghazal, R Ward, G Pratt, J Starczynski, T Lin, C Rowntree & C Fegan. (2006) CD38+ chronic lymphocytic leukaemia cells co-express high levels of ZAP-70 and are functionally distinct from their CD38− counter-parts. Leukemia 20:4, pages 743-744.
Crossref
Crossref
B T Pittner, T D Shanafelt, N E Kay & D F Jelinek. (2005) CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation. Leukemia 19:12, pages 2264-2272.
Crossref
Crossref
Alexey V. Danilov, Andreas K. Klein, Henry J. Lee, Diana Velez Baez & Brigitte T. Huber. (2005)
Differential control of G
0
programme in chronic lymphocytic leukaemia: a novel prognostic factor
. British Journal of Haematology 128:4, pages 472-481.
Crossref
Crossref
Peter Bettelheim, Heinz Diem & Thomas Nebe. (2004) Durchflußzytometrische Typisierung der B-Zell Non-Hodgkin-Lymphome / Flow cytometric typing of B-cell Non Hodgkin lymphoma. LaboratoriumsMedizin 28:5, pages 410-423.
Crossref
Crossref
Tait D. ShanafeltSusan M. GeyerNeil E. Kay. (2004) Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL. Blood 103:4, pages 1202-1210.
Crossref
Crossref
B T Pittner, D F Jelinek & N E Kay. (2003) CLL B cells with a bimodal CD38 expression pattern: persistence of bimodal populations despite effective therapy for B-CLL. Leukemia 18:1, pages 180-182.
Crossref
Crossref
William G. Wierda. 2004. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia
77
94
.
Gerald E. Marti & Vincent Zenger. 2004. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia
3
54
.
Eric D. Hsi & John L. Frater. 2004. Hematopathology in Oncology. Hematopathology in Oncology
145
165
.
Duncan A.E. Cochran, Caroline A. Evans, David Blinco, John Burthem, Freda K. Stevenson, Simon J. Gaskell & Anthony D. Whetton. (2003) Proteomic Analysis of Chronic Lymphocytic Leukemia Subtypes with Mutated or Unmutated Ig VH Genes. Molecular & Cellular Proteomics 2:12, pages 1331-1341.
Crossref
Crossref
Eric D Hsi & Imran Mirza. (2003) Update in the pathologic features of mature B-cell and T/NK-cell leukemias. Seminars in Diagnostic Pathology 20:3, pages 180-195.
Crossref
Crossref
Eric D. Hsi, Kenneth J. Kopecky, Frederick R. Appelbaum, David Boldt, Tom Frey, Margaret Loftus & Mohamad A. Hussein. (2003) Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemia. British Journal of Haematology 120:6, pages 1017-1025.
Crossref
Crossref
Ivan Aksentijevich & Ian W. Flinn. (2003) Chronic lymphocytic leukemia: advances in biology and therapeutics. Current Opinion in Oncology 15:1, pages 16-22.
Crossref
Crossref
Giovanni D'ArenaGiuseppe NunziataGiuseppe CoppolaMaria Luigia VigliottiAlfredo TartaroneNicola CarpinelliRosella MateraRosario Colella BisognoGiuseppe PistoleseNicola Di Renzo. (2002) CD38 expression does not change in B-cell chronic lymphocytic leukemia. Blood 100:8, pages 3052-3052.
Crossref
Crossref
Federico Caligaris-Cappio, Alessandro Cignetti, Luisa Granziero & Paolo Ghia. (2002) Chronic lymphocytic leukaemia: a model for investigating potential new targets for the therapy of indolent lymphomas. Best Practice & Research Clinical Haematology 15:3, pages 563-575.
Crossref
Crossref
Naoko Ishibe, Maher Albitar, Iman B. Jilani, Lynn R. Goldin, Gerald E. Marti & Neil E. Caporaso. (2002) CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is not. Blood 100:3, pages 1100-1101.
Crossref
Crossref
Terry J. HamblinJenny A. OrchardRachel E. IbbotsonZadie DavisPeter W. ThomasFreda K. StevensonDavid G. Oscier. (2002) CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 99:3, pages 1023-1029.
Crossref
Crossref